Table 2.
DIVs | SCO frequency | SCO amplitude | ||
---|---|---|---|---|
(nM) (95% CI) | Max. inhib. (%) (95% CI) | (nM) (95% CI) | Max. inhib. (%) (95% CI) | |
6 | 139.6 (73.0, 262.9) | 100.0 (82.9, 124.7) | 37.6 (22.5, 62.3) | 100.0 (88.6, 112.7) |
8 | 190.8 (126.4; 1,471.0) | 90.9 (73.6, 206.8) | 21.3 (13.6, 33.4) | 88.2 (80.0, 97.2) |
10 | N.D. | a | 29.8 (20.3, 43.5) | 67.8 (61.9, 74.1) |
12 | N.D. | a | 78.1 (26.2, 222.2) | 60.5 (43.8, 85.5) |
Note: The half-maximal inhibitory concentration () values and maximum inhibition were obtained by fitting the data in Figure 3B with a nonlinear logistic equation using Prism GraphPad software. CI, confidence interval; DIV, days in vitro; DM, deltamethrin; Max. inhib., maximal inhibition; SCO, spontaneous oscillations; N.D., not determined.
Since the data obtained from 10 and 12 DIV did not permit curve fitting, the maximal inhibition was reported at DM.